Lymphatic Vessels in the Dental Pulp: Comparison
View Latest Version
Please note this is a comparison between Version 1 by Kamila Wisniewska and Version 2 by Conner Chen.

It is debatable whether lymphatic vessels exist in the dental pulp. Most researchers confirm their presence; however, the lymphatic system in the dental pulp is much less developed compared to other tissues of the body. Lymphangiogenesis occurs in the dental pulp with inflammatory changes as a response to inflammatory stimuli acting on the tooth. If lymphangiogenesis is defined as the development of lymphatic vessels from already existing ones, such a mechanism is possible only when lymphatic vessels are present in healthy teeth.

  • histology
  • human dental pulp
  • immuhistochemistry
  • dental pulp
  • lymphatic vessels

1. Lymphatic System in the Body

The lymphatic system is an open circulatory system for lymph fluid. The lymphatic system consists of lymphatic vessels, lymph nodes and accessory organs, including the bone marrow, spleen, thymus and tonsils. Lymph is formed in the tissues from intercellular fluid and then flows towards the capillaries, larger lymphatic trunks and lymph nodes, reaching the thoracic duct that ascends to the left subclavian vein [1][2][3][4]. Lymph mediates the exchange of components between blood and other body tissues, transports fats and helps remove excess fluids and toxins from the body. Lymphocytes are formed and then they mature in the lymphatic system. Lymphatic vessels remove cellular debris and bacteria from the site of  inflammation. Excess fluid and large macromolecules, such as plasma proteins, are removed from the tissues and return to the blood [5][6]. The presence of valves that prevent the backflow of lymph is a significant feature of lymphatic vessels [7]. The main function of lymphatic vessels is the reabsorption of fluids from the interstitial space back into the circulatory system. This involves the transport of proteins, including antibodies and cells [1].

Research concerning the lymphatic system began in the 17th century. Light microscopy revealed thin white vessels distributed in the mesentery and over the upper intestinal wall. The vessels were called “venae albae aut lacteae”: “venae” due to their resemblance to veins, “albae” to distinguish them from blood vessels, and “lacteae” due to the milk-like fluid they contain [8]. Lymphatic valves were visualised; the thoracic duct and its opening into the left subclavian vein were found. Lymph flow into the circulatory system was also described. Lymph nodes were found to act as filters in the lymphatic system. Lymphatic fluid from any area of the body drains through the lymphatic system to a specific lymph node and then to other lymph nodes. Those studies developed a better understanding of lymphatic anatomy and lymphatic circulation [9][10].

Lymphatic vessels are found in most tissues of the body. The head and neck region has an extensive network of lymphatic vessels and one-third of all human lymph nodes. Lymph containing antigens from the periodontium and teeth flows to the submandibular—anterior, medial, and posterior—lymph nodes and to the submental lymph nodes. The lymph is then transported to the deep jugular nodes, whose efferent vessels form the jugular trunk from where it enters the venous angle formed by the junction of the internal jugular vein and the subclavian vein [2].

The fibres that are present in soft tissues and anchor the initial lymphatic vessels are composed of fibrillin and resemble the elastic microfibres with which they are connected. They enable tension to be transferred to the surrounding collagen fibres, ensuring elongation and relaxation of lymphatic vessels. This phenomenon is associated with lymph flow [4][11]. The presence and proper function of lymphatic vessels appears to depend on the distribution of local connective tissue.

2. Visualisation of Lymphatic Vessels in Soft Tissues

  1. Visualisation of Lymphatic Vessels in Soft Tissues

Most lymphatic vessels are located in soft tissues of the human body; hence, there are many methods that have been applied to their evaluation. The current standard for the imaging of lymphatic flow is the use of isotopes in lymphoscintigraphy. Indicators based on radionuclides are most frequently used. This leads to low-resolution images and the vessels are not clearly visible [7][12][13]. None of the known lymphoscintigraphy methods have undergone the standardisation required for daily use, as many hospitals use different radioisotopes with varying radioactivity under various data interpretation standards [14].

Fluorescence lymphography is an alternative method for determining lymph flow in lymphatic vessels. Indocyanine green is water-soluble and has been widely used in the evaluation of cardiac output, liver function and angiography for more than half a century. It contains sodium iodide; thus, it should be used with caution in patients with a history of iodine allergy [7][14]. Fluorescence lymphography is a safe and economical method that is less invasive than lymphoscintigraphy. It enables measurements whether sitting or standing. However, only vessels at the skin surface are detected, making it difficult to visualise deep vessels that run in interstitial spaces. Compared to traditional lymphoscintigraphy, the equipment used in fluorescence lymphography is less expensive, minimally invasive and provides real-time imaging. Unno et al. [14] measured the dye flow time in the lower limb during the standing position, supine position, standing position during muscle massage, and standing position while performing exercise on an ergometer exercise bike (50 W at 50 rpm./min.) in healthy volunteers for 14 days. The study revealed that the lymph flow time was shorter in the supine position compared to the standing position. The standing position creates hydrostatic pressure that causes lymph to flow against gravity. The lymph flow time was shorter during muscle massage and during exercise because the lymph flow was forced.

Laser Doppler flowmetry (LDF) is an effective tool for monitoring pulp blood flow and makes it possible to check the pulp vitality [15]. Suzuki et al. [12] performed an ultrasound examination of blood flow in the blood vessels in parallel with the lymphatic system tests. Moreover, they performed plethysmography, i.e., the measurement of changes in blood flow through peripheral vessels close to the body surface area. The aforementioned examinations proved that lymphatic vessels have a parallel course of blood vessels. The difficulty in assessing the presence of lymphatic vessels in the dental pulp is caused by the hard tissue environment of the tooth.

3. Characteristics of the Dental Pulp

The dental pulp is a specific type of connective tissue. It contains cells, fibres, intercellular substance, nerve endings, blood and lymph vessels. There are numerous veno-venous and arterio-venous anastomoses between the vessels in the pulp, leaving the area open and independent of a single source of blood supply. They provide nutrition to the tissues and equalise pressure in the excretory vessels during inflammatory processes [16].
The dental pulp is surrounded by rigid walls of dentine, a layer of enamel and root cementum. Some specific situations require increased vessel density. However, excessive blood vessel growth can be harmful and lead to pulpitis. This is due to the limited space of the pulp chamber of the tooth. When the fluid pressure in the dental pulp increases until it reaches vascular pressure, this can result in ischaemia and risk of necrosis of the dental pulp [17][18].
Unlike lymphatic vessels in other tissues, lymphatic vessels in the dental pulp are not surrounded by elastic fibres from the surrounding connective tissue; only a few anchoring fibres are present. Therefore, lymphatic vessels are directly connected to surrounding collagen fibres, forcing them to resist intracellular pressure and remain open [19][20]. A drop in blood pressure in the pulp is relatively small [21] compared to, for example, skeletal muscles [22]. Changes in circulation in adjacent tissues, such as the periodontal ligament, gingiva and alveolar bone, can affect blood circulation in the dental pulp.
Studies have found that tooth movement during chewing acts as an additional external stimulator of lymph flow in lymphatic vessels, leaving the pulp and reaching the periodontal ligaments. Lymphatic vessels found in the periodontal ligament area run towards the alveolar bone and between the teeth, connecting with one another [23][24].
During tooth development, the dentine-forming cells—odontoblasts—of the pulp-dentine complex produce primary dentine, which is the main material of the tooth. In a mature tooth, the process of dentine formation continues. As the body ages, the dental pulp accumulates more layers of dentine. It is initially responsible for the formation of the primary pulp. In a fully formed tooth, it forms the secondary dentine. Aging reduces the dimensions of the pulp chamber due to the formation of tertiary dentine and atrophy of the dental pulp. It begins with apoptosis of odontoblasts, fibroblasts, and the accumulation of hydroxyapatite crystals, and it is accompanied by decreased perfusion due to the narrowing of the apical foramen by dental cementum deposits. At the same time, the number and diameter of nerve fibres decreases. Blood vessels also become calcified [16].
The tertiary dental pulp is also formed as a defensive reaction of the dental pulp to external irritants such as tooth surface abrasion, caries development and preparations for fillings. Ultimately, this leads to the thickening of the mineralised barrier that separates the pulp chamber from the oral microbial environment [25][26].
In teeth with caries, dilated vessels with a structure typical of lymphatic vessels were found, i.e., thin walls, irregular shape, no erythrocytes in the lumen of the lymphatic vessel [27]. Dental pulpitis additionally causes deposition of damaged secondary dentine or deposition of mineral salts in the form of free denticles (pulp stones) or pulp stones adhering to hard tissues (adherent denticles) [28]. The more mature the teeth, the smaller the pulp chamber. This is related to the deposition of secondary dentine. Hence, the thesis that the lymphatic system of the teeth can develop with aging when the dimensions of the surrounding tissues continue to decrease must be considered questionable [29].
Deep carious lesions are the most common cause of dental pulpitis. However, there are indications that carious bacteria may enter the dental pulp from the blood vessels as a result of septicaemic phenomena [30]. The inflammation is accompanied by increased angiogenesis; lymphatic vessels may also appear [31]. To date, it has not been proved whether the lymphatic vessels in the pulp are in contact with the adjacent lymphatic vessels or they are a secondary response to increased angiogenesis due to the inflammatory process. Lymphatic vessels are most frequently formed from already existing ones. The formation of lymphatic vessels in response to inflammation is a matter of dispute [32].

3.1. Development of the Inflammatory Process in the Dental Pulp

When the enamel and dentine surfaces are damaged by a deep carious lesion or a dental tissue fracture due to trauma, bacterial colonisation of the root canals can occur, as well as formation of biofilm that infects the dental pulp [33][34][35]. Bacteria are very frequently subject to colonisation in spaces beyond the reach of dental instruments and antimicrobials. Proteins from remaining necrotic tissues and bacterial adhesives provide nutrients for their survival [36]. In severe caries, dentinal tubules are the main route of discharge of bacterial metabolites such as lactic acid, propionic acid and acetic acid [37]. At low pH due to the presence of the aforementioned acids, a specific byproduct is activated—lipoteicholic acid (LTA). LTA is extracellularly released by acidogenic Gram-positive bacteria [37][38].
Odontoblasts show expression of toll-like receptors that recognise specific pathogens and trigger the recruitment of other immune cells, such as dendritic cells and lymphocytes [39][40]. Other molecules, including β-defensin [41] or transforming growth factor β (TGF-β), are also released by odontoblasts. β-defensin has a bactericidal effect on bacteria that are commonly involved in caries, such as Streptococcus mutans and Lactobacillu ssp. [41]. TGF-β controls homeostasis by exerting pro-inflammatory effects in the early stage of injury, and anti-inflammatory and profibrotic effects in the late stage of injury [42][43].
Reuptake of extravasated fluids in the dental organ is of great importance in terms of the process of maintaining homeostasis of the dental pulp and the nerves and odontoblasts contained in it. The lymphatic system provides an alternative means of recirculating intercellular fluid while becoming a defensive element against potential bacterial infection associated with pathological processes in the oral cavity. The understanding of the mechanisms of angiogenesis and lymphangiogenesis during these processes may be beneficial for more effective disease management; however, further research is necessary.
Currently, the standard for identification of lymphatic vessels and imaging of lymph flow is the use of isotopes in lymphoscintigraphy. In the case of the dental pulp, however, the usefulness of this method is limited due to the specificity of the structure and location of dental pulp.
Inflammation-induced lymphangiogenesis is a widely accepted concept; however, the intrinsic mechanisms concerning the interaction between inflammatory cells and lymphatic endothelial cells are not fully understood [32]. Macrophages, monocytes and neutrophils were found to be involved in inflammation-induced lymphangiogenesis, but the role of mast cells, plasma cells and eosinophils is still a matter of dispute [32][44][45][46].
In lymphangiogenesis, after exposure to inflammatory stimuli, the best described signaling pathways include: vascular endothelial growth factor C/vascular endothelial growth factor receptor-3 (VEGF-C/VEGFR-3) and vascular endothelial growth factor A/vascular endothelial growth factor receptor-2 (VEGF-A/VEGFR-2) [47][48][49][50][51][52].
The healing process of the dental pulp is associated with the expression of several proangiogenic growth factors, such as platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), fibroblast growth factor 2 (FGF-2), angiogenin, angiopoietin, epidermal growth factor, heparin-binding epidermal growth factor, hepatocyte growth factor, leptin, and placental growth factor. Many of these proangiogenic growth factors may also directly or indirectly stimulate lymphangiogenesis [53][54].

3.2. The Presence of Lymphatic Vessels in the Dental Pulp of Various Animal Species

Despite many studies, the dental lymphatic system is still debated due to the new methods implemented in the research. The first studies were based on light and electron microscope, radioisotope scanning and tissue fluid pressure measurement [24].
Some of the investigations proved the existence of lymphatic vessels in the dental pulp based on the characteristic lumen structure of lymphatic vessels by means of transmission electron microscopy [18], characteristics of lymphatic vessels in inflammatory dental pulp [20], enzyme-histochemical staining using 5′nucleotidase [55] or immunohistochemical staining [56]. Some of the reports denied the presence of lymphatic vessels in the dental pulp [29]. Martin et al. (2010) suggested that capillary blood vessels and the tissue interstitium may serve as a closed circulatory system such as lymphatic vessels [29]. Gerli et al. (2010) reported that the presence of lymphatic vessels is probably a false-positive caused by fiber bundles and inflammatory cells which were stained due to the lack of blocking [57].
In recent years, immunohistochemical markers, which are characteristic of lymphatic vessel endothelium, have become available on the market [29][58][59]. Their application along with the use of electron microscope and enzyme-histochemical procedures allow to confirm the presence of lymphatic vessels [19][60].
Table 1, Table 2, Table 3, Table 4 and Table 5 present the studies of lymphatic vessels in the structures of the tooth in various species with different evaluation techniques.
Table 1. Examination of the presence of lymph vessels in the dental pulp with the use of a light microscope [61].
Author, Year Species Lymphatic Vessel in the Dental Pulp
Table 3. Examination of the presence of lymph vessels in the dental pulp using a light and electron microscope [61].
Author Species Lymphatic Vessel in the Dental Pulp
Table 4. Examination the presence of lymphatic vessels in the dental pulp method enzyme histochemistry [61].
Author Species Lymphatic Vessel in the Dental Pulp
Author Species Method Lymphatic Vessel in the Dental Pulp
Schweitzer, 1907 [62] rabbit, monkey, dog +
Magnus, 1922 [63] human, ox +
Fish, 1927 [64
Bernick, 1977b
[
[
75
]
human
+
Observation: “+” positive result, “−” negative result, “ ± “ equivocal result.
Table 2. Examination of the presence of lymph vessels in the dental pulp with the use of a microscope electron microscope [61].
Author Species Lymphatic Vessel in the Dental Pulp
Kukletová, 1979 [76] calf +
Eifinger, 1970 [82] Dahl, 1973 [73] human
] dog +
70
]
Aoyama et al., 1995 [human 55± ] dog, mice, guinea pig, rabbit, human
dog +
Brown et al., 1969 [71] dog +
+
Gängler et al., 1980 [77
Sawa et al., 1998 human [90]+
human light microscope, IHC: mAb-D, anti-L + −
Aoyama, 1996 [87] human + ] human, rat, cat, dog −
Pimenta et al., 2003 [91] human light microscope, IHC: anti-VEGFR-3, anti-CD31 + Bishop, 1990 [18] Matsumoto et al., 1997 [88]cat human + Noyes et al., 1929 [65]
Vongsavan et al., 1992 [78rabbit, dog ] cat+
Matsumoto et al., 2002 [89]− MacGregor, 1936 [66 Marchetti, 1996 [79] human +
Qi et al., 2000 [80] human +
Zhang et al., 2000
Takada, 1973 [83]+
Marchetti et al., 1990 [84] human +
rat, hamster, monkey, human +
Observation: “+” positive result.
Table 5. Examination of the presence of lymphatic vessels in the dental pulp using the immunohistochemical method [61].
Berggreen, 2009
[24] mice, rats light and fluorescence microscope, IHC: anti-LYVE-1, anti-VEGFR-3 +
Masuyama et al., 2009 [92] mice light microscope, IHC: anti-LYVE-1 +
] cat, monkey, dog, guinea pig +
Marchetti et al., 1991 [85] human + Sulzmann, 1955 [67] dog +
Marchetti, 1992 [20] human
Martin, 2010 [29+
Gerli et al., 2010 ] dog Balogh et al., 1957 [68] [human ±
81] human +
Observation: “+” positive result, “−” negative result.
[
57
]
human light and electro microscope, Western blotting, method IHC: anti-LYVE-1, anti-VEGFR, D2-40, Prox-1 −
light microscope, IHC: anti-LYVE-1, anti-Prox-1 −
Marchetti et al., 2002 [86] human +
Takahashi et al., 2012 [93] mice Isokawa, 1960 [69] Oehmke, 2003 dog [19]− human +
Ruben et al., 1971 [72] dog +
Dahl et al., 1973 [73] human −
Bernick, 1977b [70] human (healthy pulp) +
Bernick, 1977a [27] human (inflamed pulp) +
Frank et al., 1977 [74] human +
Observation: “+” positive result, “−” negative result, “ ± “ equivocal result.
light microscope, IHC: anti-VEGF-C, anti-VEGF-D, anti-VEGRF-3; anti-vWF
+
Rodd et al., 2003
Observation: “+” positive result, “−” negative result.

4. Molecular Markers of Lymphangiogenesis

Lymphangiogenesis is regulated by vascular endothelial growth factors: VEGF-C and VEGF-D, and their receptors: VEGFR-2, VEGFR-3, neuropilin-2 (VEGFR-3 co-receptor), angiopoietic factors and their receptors. Endothelial cells of lymphatic vessels are characterised by the expression of the Prox-1 transcription factor, the presence of molecules such as Lymphatic Vessel Endothelial Receptor 1 (LYVE-1), podoplanin (PDPN) and integrin α2 (adhesion molecule). The aforementioned lymphatic endothelial cell markers can also be found in other cells. Therefore, these markers are not exclusive to lymphatic vessels. The immunohistochemical evaluation of lymphangiogenesis uses preferably a combination of lymphatic markers (Anti-Prox 1, Anti-VEGFR-3, Anti-LYVE1, Anti-PDPN). They enable an objective evaluation of lymphangiogenesis. Transcription factors, such as Prox-1, regulating the differentiation of precursor lymphatic vessels (Table 6). Lymphatic endothelial cell differentiation is also influenced by, i.a., VEGF-C, VEGF-D, angiopoietin-2, transmembrane ligand—ephrin-B2, neuropilin-2 receptor protein and transmembrane glycoprotein—podoplanin. At the inflammatory site, lymphangiogenesis is regulated by the same factors that affect lymphatic vessel development in terms of individual development [94].

Table 6. Examples of markers used in immunohistochemical studies.

Antibody

Specificity

VEGF-C

Vascular endothelial growth factor C

VEGF-D

Vascular endothelial growth factor D

VEGFR-2

Vascular endothelial growth factor receptor 2

VEGFR-3

Vascular endothelial growth factor receptor 3

Prox1

Prospero homeobox protein 1

LYVE-l

Lymphatic vessel endothelial hyaluronan receptor 1

D2-40

Podoplanin and O-linked sialoglycoprotein expressed on lymphatic endothelial cells

The hyaluronic acid receptor LYVE-1 is expressed by the endothelium of lymphatic vessels on the lumen and tissue sides. LYVE-1 promotes receptor-dependent endocytosis of hyaluronic acid, suggesting the involvement of LYVE-1 in transcytosis of macromolecules [95][96][97]. Studies show that growth factors such as PDGF, VEGF-A, VEGF-C, VEGF-D and human placental growth factor (human PGF), containing the cell-surface retention sequence (CSR) that can be found in hyaluronic acid, are LYVE-1 ligands (antibodies directed against the first endothelial receptor for hyaluronic acid). Following the formation of the aforementioned LYVE-1 ligand complex, the cell-surface retention sequence binding protein-1 (CRSBP-1) is phosphorylated, initiating a signaling cascade that results in the opening of lymphatic endothelial intercellular junctions [96]. When choosing LYVE-1 as a marker in the evaluation of lymphangiogenesis, it should be noted that the LYVE-1 molecule can be degraded during the inflammatory process [98].

Prospero-related homeobox 1 (Prox-1) is a transcription factor located in the nucleus of lymphatic endothelial cells [99][100]. The released Prox-1 factor determines the differentiation of lymphatic endothelial cells, the maintenance of the characteristics of mature lymphatic vessels, as well as the proliferation and differentiation of other cell types (e.g., nerve cells). It is also involved in the induction of the expression of E1 cytokines, which regulates cell migration from G1 phase to S phase. Anti-Prox-1 antibodies selectively detect lymphatic endothelial cells in various animal species against the transcription factor [100][101]. During Prox1 labeling, Martin et al. [102] did not find any positive nuclear immune response in 2145 pulp preparations in three sections: apical, medial and occlusal areas of canine teeth.

The VEGFR-3, also known as Flt4 (fms-related tyrosine kinase 4), is selectively present on lymphatic endothelial cells; it is also expressed on the endothelial surface of blood vessels. The Flt4 was first detected on the surface of lymphatic vessels [103][104][105]. It plays a central role in the regulation of lymphangiogenesis, as it is a signaling receptor for VEGF-C and VEGF-D—growth factors that are specific to lymphatic vessels. The receptor stimulation activates the proliferation and migration of lymphatic endothelial cells. It also prevents apoptosis [106][107][108]. In mature venous vessels, VEGFR-3 disappears on the surface of endothelial cells and becomes specific to lymphatic vessels. The VEGF gene expression by pulp fibroblasts is induced by bacteria such as Pseudomonas endodontalis, Pseudomonas gingivalis and Pseudomonas intermedia, which may be associated with the development of inflammation within the dental pulp by stimulating VEGF products [109].

Infected tissues enhance the expression of inflammatory mediators. It has been noted that this expression is strongly influenced by cytokines that induce the VEGF mRNA gene expression in human dental pulp and human gingival fibroblasts. This may partially contribute to the damage of dental pulp and periapical tissues by expanding the vascular network, which in turn could increase inflammation. Lipopolysaccharides (LPS) produced by Gram-negative (G−) bacteria and lipoteichoic acid (LTA) produced by Gram-positive (G+) bacteria under VEGF expression pattern also contribute to inflammation. These bacteria are found in deep carious lesions and in reversible pulpitis. Lipopolysaccharides determine cytotoxicity, pyrogenicity and macrophage activation [110]

Podoplanin is a transmembrane protein that appears on the surface of lymphatic endothelial cells on the lumen side and in small amounts in the tissue area. It is also found on the surface of other cells, e.g., osteocytes. Podoplanin enables lymphatic vessels to mature. It is recognised by the marker D2-40, which enables its identification by immunohistochemical examinations [111]. Angiopoietin and its receptor contribute to lymphangiogenesis; however, their function is not fully understood [112]. Despite many indications of the presence of lymphatic vessels in the dental pulp, this problem is still open and requires further research.

 

5. Conclusions

The presence of lymphatic vessels in the dental pulp is a matter of dispute. Most researchers confirm their presence; however, the lymphatic system in the dental pulp is much less developed compared to other tissues of the body.

Lymphangiogenesis occurs in the dental pulp with inflammatory changes as a response to inflammatory stimuli acting on the tooth. If lymphangiogenesis is defined as the development of lymphatic vessels from already existing ones, such a mechanism is possible only when lymphatic vessels are present in healthy teeth. Research papers have not conclusively proved whether lymphatic vessels can form in the dental pulp. The use of an immunohistochemical examination is very likely to prove the presence of lymphatic system in dental tissues. However, the evaluation of the lymphatic system of the teeth is problematic because it is quite difficult to clearly distinguish lymphatic vessels from small blood vessels. Understanding the mechanisms of angiogenesis and lymphangiogenesis during these processes can be beneficial for more effective treatment of diseases, but further research is needed.

References

  1. 1. Ratajska, A.; Jankowska-Steifer, E.; Czarnowska, E.; Flaht, A.; Radomska-Leśniewska, D.; Morfogeneza, budowa i właściwości naczyń limfatycznych. Postepy Hig. Med. Dosw. 2012, 66, 901–912.
  2. Rui-Cheng Ji; Macrophages are important mediators of either tumor- or inflammation-induced lymphangiogenesis. Cellular and Molecular Life Sciences 2011, 69, 897-914, 10.1007/s00018-011-0848-6.
  3. Foskett, A.M.; Chakraborty, S.; Muthuchamy, M.. Lymphangiogenesis. In Immunology of the Lymphatic System; Springer: NY, USA, 2013; pp. 3–33.
  4. 4. Breslin, J.W.; Yang, Y.; Scallan, J.P.; Sweat, R.S.; Adderley, S.P.; Murfee, W.L.; . Lymphatic Vessel Network Structure and Physiology. Comprehensive Physiology 2018, -, 207-299.
  5. Imke Albrecht; Gerhard Christofori; Molecular mechanisms of lymphangiogenesis in development and cancer. The International Journal of Developmental Biology 2011, 55, 483-494, 10.1387/ijdb.103226ia.
  6. Matthew G. Butler; Sumio Isogai; Brant M. Weinstein; Lymphatic development. Birth Defects Research Part C: Embryo Today: Reviews 2009, 87, 222-231, 10.1002/bdrc.20155.
  7. Suami, H.; Chang, D.; Skoracki, R.; Yamada, K.; Kimata, Y.; Using indocyanine green fluorescent lymphography to demonstrate lymphatic architecture. Lymphoedema 2012, 7, 25–29.
  8. Domenico Ribatti; Historical overview of lymphangiogenesis. Current Opinion in Immunology 2018, 53, 161-166, 10.1016/j.coi.2018.04.027.
  9. Gianfranco Natale; Guido Bocci; Menico Ribatti; Scholars and scientists in the history of the lymphatic system. Journal of Anatomy 2017, 231, 417-429, 10.1111/joa.12644.
  10. Eelco De Bree; J. Tsiaoussis; G. Schoretsanitis; The History of Lymphatic Anatomy and the Contribution of Frederik Ruysch. Hellenic Journal of Surgery 2018, 90, 308-314, 10.1007/s13126-018-0495-6.
  11. Celeste Sánchez‐Romero; Ronell Bologna‐Molina; Adalberto Mosqueda‐Taylor; Oslei Paes De Almeida; Immunohistochemical expression of podoplanin (D2-40), lymphangiogenesis, and neoangiogenesis in tooth germ, ameloblastomas, and ameloblastic carcinomas. Journal of Oral Pathology & Medicine 2016, 46, 618-624, 10.1111/jop.12524.
  12. Minoru Suzuki; Naoki Unno; Naoto Yamamoto; Motohiro Nishiyama; Daisuke Sagara; Hiroki Tanaka; Yuuki Mano; Hiroyuki Konno; Impaired lymphatic function recovered after great saphenous vein stripping in patients with varicose vein: Venodynamic and lymphodynamic results. Journal of Vascular Surgery 2009, 50, 1085-1091, 10.1016/j.jvs.2009.06.003.
  13. Naoki Unno; Motohiro Nishiyama; Minoru Suzuki; Hiroki Tanaka; Naoto Yamamoto; Daisuke Sagara; Yuuki Mano; Hiroyuki Konno; A novel method of measuring human lymphatic pumping using indocyanine green fluorescence lymphography. Journal of Vascular Surgery 2010, 52, 946-952, 10.1016/j.jvs.2010.04.067.
  14. N. Unno; M. Nishiyama; M. Suzuki; N. Yamamoto; K. Inuzuka; D. Sagara; H. Tanaka; H. Konno; Quantitative Lymph Imaging for Assessment of Lymph Function using Indocyanine Green Fluorescence Lymphography. European Journal of Vascular and Endovascular Surgery 2008, 36, 230-236, 10.1016/j.ejvs.2008.04.013.
  15. Naoki Unno; Kazunori Inuzuka; Minoru Suzuki; Naoto Yamamoto; Daisuke Sagara; Motohiro Nishiyama; Hiroyuki Konno; Preliminary experience with a novel fluorescence lymphography using indocyanine green in patients with secondary lymphedema. Journal of Vascular Surgery 2007, 45, 1016-1021, 10.1016/j.jvs.2007.01.023.
  16. Staszyk, C.; Duesterdieck, K.F.; Gasse, H.; Bienert, A.; lmmunohistochemical ldentification of Lymphatic Vessels in the Periodontium of Equine Cheek Teeth. J. Vet. Dent. 2005, 22, 227–232.
  17. Jańczuk, Z.; Kaczmarek, U.; Lipski, M. Stomatologia Zachowawcza z Endodoncją-Zarys Kliniczny; PZWL: Waszawa, Poland, 2014.
  18. Heyeraas, K.J. Pulpal hemodynamics and interstitial fluid pressure: Balance of transmicrovascular fluid transport. J. Endod. 1989, 15, 468–472.
  19. Bishop, M.A.; Malhotra, M. An investigation of lymphatic vessels in the feline dental pulp. Am. J. Anat. 1990, 187, 247–253.
  20. Oehmke, M.J.; Knolle, E.; Oehmke, H.J.; Tranasi, M.; Sberna, M.T.; Zizzari, V.; D’Apolito, G.; Mastrangelo, F.; Salini, L.; Stuppia, L.; et al. Lymph drainage in the human dental pulp. Int. Orthop. 2003, 311, 510–516.
  21. Marchetti, C.; Poggi, P.; Calligaro, A.; Casasco, A. Lymphatic Vessels of the Human Dental Pulp in Different Conditions. Anat. Rec. 1992, 33, 27–33.
  22. Tonder, K.; Naess, G. Microvascular pressure in the dental pulp and gingiva in cats. Acta Odontol. Scand. 1979, 37, 161–168.
  23. Bjornberg, J. Forces involved in transcapillary fluid movement in exercising cat skeletal muscle. Acta Physiol. Scand. 1990, 140, 221–236.
  24. Staszyk, C.; Duesterdieck, K.F.; Gasse, H.; Bienert, A. lmmunohistochemical ldentification of Lymphatic Vessels in the Periodontium of Equine CheekTeeth. J. Vet. Dent. 2005, 22, 227–232.
  25. Berggreen, E.; Haug, S.R.; Mkonyi, L.E.; Bletsa, A. Characterization of the dental lymphatic system and identification of cells immunopositive to specific lymphatic markers. Eur. J. Oral Sci. 2009, 117, 34–42.
  26. Tjäderhane, L.; Haapasalo, M. The dentin-pulp border: A dynamic interface between hard and soft tissues. Endod. Top. 2009, 20, 52–84.
  27. Alexandru-Andrei, I.; Perlea, P.; Irina-Maria, G.; Mihai, M.; Loredana, M.; Iren, M.; Sînziana, S.; Erdoğan, Ș.; Andrei, I. Molecular Mechanisms of Dentine-Pulp Complex Response Induced by Microbiome of Deep Caries. ARS Med. Tomitana 2019, 25, 53–60.
  28. Bernick, S. Morphological Changes to Lymphatic Vessels in Pulpal Inflammation. J. Dent. Res. 1977, 56, 841–849.
  29. Kisiel, M.; Laszewicz, J.; Frątczak, P.; Dąbrowska, B.; Pietruska, M.; Dąbrowska, E. Denticles. A literature review. Prog. Health Sci. 2015, 5, 200–204.
  30. Martin, A.; Gasse, H.; Staszyk, C. Absence of lymphatic vessels in the dog dental pulp: An immunohistochemical study. J. Anat. 2010, 217, 609–615.
  31. Farges, J.C.; Alliot-Licht, B.; Renard, E.; Ducret, M.; Gaudin, A.; Smith, A.J.; Cooper, P.R. Dental Pulp Defence and Repair Mechanisms in Dental Caries. Mediat. Inflamm. 2015, 2015.
  32. Detmar, M.; Hirakawa, S. The formation of lymphatic vessels and its importance in the setting of malignancy. J. Exp. Med. 2002, 196, 713–718.
  33. Cimpean, A.M.; Raica, M. Lymphangiogenesis and Inflammation-Looking for the “Missing Pieces” of the Puzzle. Arch. Immunol. Ther. Exp. 2015, 63, 415–426.
  34. de Paz, L.E.C.; Bergenholtz, G.; Svensäter, G.; Dunavant, T.R.; Regan, J.D.; Glickman, G.N.; Solomon, E.S.; Honeyman, A.L.; Larsen, T. Comparative Evaluation of Endodontic Irrigants against Enterococcus faecalis Biofilms. J. Endod. 2006, 36, 527–531.
  35. de Paz, L.E.C.; Bergenholtz, G.; Svensäter, G. The Effects of Antimicrobials on Endodontic Biofilm Bacteria. J. Endod. 2010, 36, 70–77.
  36. Larsen, T. Susceptibility of Porphyromonas gingivalis in biofilms to amoxicillin, doxycycline and metronidazole. Oral Microbiol. Immunol. 2002, 17, 267–271.
  37. de Paz, L.E.C.; Zapata, R.O. Challenges for root canal irrigation: Microbial biofilms and root canal anatomy. Endo-Endod. Pract. Today 2019, 13, 91–100.
  38. Hahn, C.L.; Liewehr, F.R. Relationships between Caries Bacteria, Host Responses, and Clinical Signs and Symptoms of Pulpitis. J. Endod. 2007, 33, 213–219.
  39. Yoshimura, A.; Lien, E.; Ingalls, R.R.; Tuomanen, E.; Dziarski, R.; Golenbock, D. Cutting edge: Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 1999, 163, 1–5.
  40. Couve, E.; Osorio, R.; Schmachtenberg, O. The amazing odontoblast: Activity, autophagy, and aging. J. Dent. Res. 2013, 92, 765–772.
  41. Durand, S.H.; Flacher, V.; Roméas, A.; Carrouel, F.; Colomb, E.; Vincent, C.; Magloire, H.; Couble, M.-L.; Bleicher, F.; Staquet, M.-J.; et al. Lipoteichoic Acid Increases TLR and Functional Chemokine Expression while Reducing Dentin Formation in In Vitro Differentiated Human Odontoblasts. J. Immunol. 2006, 176, 2880–2887.
  42. Shiba, H.; Mouri, Y.; Komatsuzawa, H.; Ouhara, K.; Takeda, K.; Sugai, M.; Kinane, D.F.; Kurihara, H. Macrophage inflammatory protein-3α and β-defensin-2 stimulate dentin sialophosphoprotein gene expression in human pulp cells. Biochem. Biophys. Res. Commun. 2003, 306, 867–871.
  43. Piattelli, A.; Rubini, C.; Fioroni, M.; Tripodi, D.; Strocchi, R. Transforming Growth Factor-beta 1 (TGF-beta 1) expression in normal healthy pulps and in those with irreversible pulpitis. Int. Endod. J. 2004, 37, 114–119.
  44. Sloan, A.J.; Perry, H.; Matthews, J.B.; Smith, A.J. Transforming growth factor-β isoform expression in mature human healthy and carious molar teeth. Histochem. J. 2000, 32, 247–252.
  45. Miteva, M.; Galimberti, M.L.; Ricotti, C.; Breza, T.; Kirsner, R.; Romanelli, P. D2-40 highlights lymphatic vessel proliferation of angiolymphoid hyperplasia with eosinophilia. J. Cutan. Pathol. 2009, 36, 1316–1322.
  46. Kelley, P.M.; Connor, A.L.; Tempero, R.M. Lymphatic Vessel Memory Stimulated by Recurrent Inflammation. Am. J. Pathol. 2013, 182, 2418–2428.
  47. Galli, S.J.; Grimbaldeston, M.; Tsai, M. Immunomodulatory mast cells: Negative, as well as positive, regulators of immunity. Nat. Rev. Immunol. 2008, 8, 478–486.
  48. Kim, H.; Kataru, R.P.; Koh, G.Y. Regulation and implications of inflammatory lymphangiogenesis. Trends Immunol. 2012, 33, 350–356.
  49. Tammela, T.; Alitalo, K. Lymphangiogenesis: Molecular mechanisms and future promise. Cell 2010, 140, 460–476.
  50. Kim, H.; Kataru, R.P.; Koh, G.Y. Inflammation-associated lymphangiogenesis: A double-edged sword? J. Clin. Investig. 2014, 124, 936–942.
  51. Baluk, P.; Tammela, T.; Ator, E.; Lyubynska, N.; Achen, M.G.; Hicklin, D.J.; Jeltsch, M.; Petrova, T.V.; Pytowski, B.; Stacker, S.A.; et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J. Clin. Investig. 2005, 115, 247–257.
  52. Guo, R.; Zhou, Q.; Proulx, S.T.; Wood, R.; Ji, R.-C.; Ritchlin, C.T.; Pytowski, B.; Zhu, Z.; Wang, Y.-J.; Schwarz, E.M.; et al. Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis. Arthritis Rheum. 2009, 60, 2666–2676.
  53. Wirzenius, M.; Tammela, T.; Uutela, M.; He, Y.; Odorisio, T.; Zambruno, G.; Nagy, J.A.; Dvorak, H.F.; Ylä-Herttuala, S.; Shibuya, M.; et al. Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. J. Exp. Med. 2007, 204, 1431–1440.
  54. El Karim, I.A.; Linden, G.J.; Irwin, C.R.; Lundy, F.T. Neuropeptides Regulate Expression of Angiogenic Growth Factors in Human Dental Pulp Fibroblasts. J. Endod. 2009, 35, 829–833.
  55. Tran-Hung, L.; Laurent, P.; Camps, J.; About, I. Quantification of angiogenic growth factors released by human dental cells after injury. Arch. Oral Biol. 2008, 53, 9–13.
  56. Aoyama, Y.; Shigemitsu, Y.; Yoshinobu, N.; Masatsugu, S.; Haruhisa, O. Lymphatic vessels in human dental pulp: An enzymehistochemical study. Jpn. J. Oral Biol. 1995, 37, 437–446.
  57. Liersch, R.; Detmar, M. Lymphangiogenesis in development and human disease. Thromb. Haemost. 2007, 90, 304–310.
  58. Gerli, R.; Secciani, I.; Sozio, F.; Rossi, A.; Weber, E.; Lorenzini, G. Absence of lymphatic vessels in human dental pulp: A morphological study. Eur. J. Oral Sci. 2010, 118, 110–117.
  59. Sleeman, J.P.; Krishnan, J.; Kirkin, V.; Baumann, P. Markers for the lymphatic endothelium: In search of the holy grail? Microsc. Res. Tech. 2001, 55, 61–69.
  60. Kato, S.; Shimoda, H.; Ji, R.-C.; Miura, M. Lymphangiogenesis and expression of specific molecules as lymphatic endothelial cell markers. Anat. Sci. Int. 2006, 81, 71–83.
  61. Sánchez-Romero, C.; Bologna-Molina, R.; Mosqueda-Taylor, A.; de Almeida, O.P. Immunohistochemical expression of podoplanin (D2-40), lymphangiogenesis, and neoangiogenesis in tooth germ, ameloblastomas, and ameloblastic carcinomas. J. Oral Pathol. Med. 2017, 46, 618–624.
  62. Stefański, T. Lymphatic System of the Dental Pulp—Systematic Review of Literature. J. Stomatol. 2013, 66, 202–220.
  63. Schweitzer, G. Über die Lymphgefässe des Zahnfleisches und der Zähne beim Menschen und bei Säugetieren. Arch. Mikr. Anat. 1907, 69, 807–907.
  64. Magnus, G. Über den Nachweis der Lymphgefäβe View publication stats in der Zahnpulpa. Dtsch. Mschr. Zahnheilk. 1922, 40, 661–666.
  65. Fish, E.W. The circulation of lymph in dentin and enamel. J. Am. Dent. Assoc. 1927, 14, 804–817.
  66. Noyes, F.B.; Ladd, R.L. The lymphatics of the dental region. Dent. Cosmos. 1929, 71, 1041–1047.
  67. MacGregor, A. An experimental investigation of the lymphatic system of the teeth and jaws. Proc. R. Soc. Med. 1936, 29, 49–78.
  68. Sulzmann, R. Beiträge zur Histologie der Zahnpulpa. I. Mitteilung. Über das Vorkommen von epitheloidzellhaltigen Gefäβstrecken und Sperrarterien (Polsterarterien und Arterienwülsten) in der Eckzahnpulpa des Schäferhundes. Z. Mikrosk. Anat. Forsch. 1955, 61, 281–303.
  69. Balogh, K.; Boros, S. Experimentelle Untersuchungen über die Lymphzirkulation der Pulpa. Österr. Z. Stomatol. 1957, 20, 393–408.
  70. Isokawa, S. Über des Lymphsystem des Zähnes. Z. Zellforsch. 1960, 52, 140–149.
  71. Bernick, S. Lymphatic vessels of human dental pulp. J. Dent. Res. 1977, 55, 70–77.
  72. Brown, A.C.; Barrow, B.L.; Gadd, G.N.; van Hassel, H.J. Tooth pulp transcapillary osmotic pressure in the dog. Arch. Oral Biol. 1969, 14, 491–502.
  73. Ruben, M.P.; Prieto-Hernandez, J.R.; Gott, F.K.; Kramer, G.M.; Bloom, A.A. Visualization of lymphatic microcirculation of oral tissues. II. Vital reprohibited lymphography. J. Periodontol. 1971, 42, 774–784.
  74. Dahl, E.; Mjör, I.A. The fine structure of the vessels in the human dental pulp. Acta Odontol. Scand. 1973, 31, 223–230.
  75. Frank, R.M.; Wiedemann, P.; Fellinger, E. Ultrastructure of lymphatic capillaries in the human dental pulp. Cell Tissue Res. 1977, 178, 229–238.
  76. Rodd, H.D.; Boissonade, F.M. Immunocytochemical investigation of neurovascular relationships in human tooth pulp. J. Anat. 2003, 202, 195–203.
  77. Kukletová, M. An electron-microscopic study of the lymphatic vessels in the dental pulp in the calf. Arch. Oral Biol. 1979, 15, 1117–1124.
  78. Gängler, P.; Mönch, M. Die morphologische Differenzierung von Kapillaren der Pulpa dentis. Zahn. Mund. Kieferheilkd. Zentralbl. 1980, 68, 198–206.
  79. Vongsavan, N.; Matthews, B. The Vascularity of Dental Pulp in Cats. J. Dent. Res. 1992, 71, 1913–1915.
  80. Marchetti, C. Weibel-Palade bodies and lymphatic endothelium: Observations in the lymphatic vessels of normal and inflamed human dental pulps. Vasa 1996, 25, 337–340.
  81. Qi, Q.; Wang, Z.; Wang, D.; Wang, W. Ultrastructure of the lymph capillaries in human dental pulp. West China J. Stomatol. 2000, 18, 222–225.
  82. Zhang, B.; Miura, M.; Ji, R.C.; Matsumoto, Y.; Yanagisawa, S.; Kato, S. Structural organization and fine distribution of lymphatic vessels in periodontal tissues of the rat and monkey: A histochemical study. Okajimas Folia Anat. Jpn. 2000, 77, 93–107.
  83. Eifinger, F.F. Die Mikromorphologie der Menschlichen Zahnpulpa; Hanser: München, Germany, 1970.
  84. Takada, T. Structure of the vessels of the dental pulp studies by light and electron microscopy, with special reference to the presence or absence of lymphatic vessels and fine structure of venules. Kaibogaku Zasshi J. Anat. 1973, 48, 118–134.
  85. Marchetti, C.; Piacentini, C. Light microscopy and electron microscopy study of the lymphatic capillaries of human dental pulp. Bull. Group. Int. Pour Rech. Sci. Stomatol. Odontol. 1990, 33, 19–23.
  86. Marchetti, C.; Poggi, P.; Calligaro, A.; Casasco, A. Lymphatic Vessels in the Healthy Human Dental Pulp. Cells Tissues Organs 1991, 140, 329–334.
  87. Marchetti, C.; Poggi, P. Lymphatic vessels in the oral cavity: Different structures for the same function. Microsc. Res. Tech. 2002, 56, 42–49.
  88. Aoyama, Y. Distribution of the lymphatic vessels in the human dental pulp: An enzyme-histochemical study. Hokkaido J. Dent. Sci. 1996, 17, 238–250.
  89. Matsumoto, Y.; Kato, S.; Miura, M.; Yanagisawa, S.; Shimizu, M. Fine structure and distribution of lymphatic vessels in the human dental pulp: A study using an enzyme-histochemical method. Cell Tissue Res. 1997, 288, 79–85.
  90. Matsumoto, Y.; Zhang, B.; Kato, S. Lymphatic networks in the periodontal tissue and dental pulp as revealed by histochemical study. Microsc. Res. Tech. 2002, 56, 50–59.
  91. Sawa, Y.; Yoshida, S.; Ashikaga, Y.; Kim, T.; Yamaoka, Y.; Suzuki, M. Immunohistochemical demonstration of lymphatic vessels in human dental pulp. Tissue Cell 1998, 30, 510–516.
  92. Pimenta, F.J.G.S.; Sá, A.R.; Gomez, R.S. Lymphangiogenesis in human dental pulp. Int. Endod. J. 2003, 36, 853–856.
  93. Masuyama, M.; Fujimura, A. Lymphatic distribution in the mouse periodontal ligament. Microvasc. Rev. Commun. 2009, 3, 2–10.
  94. Takahashi, S.; Ambe, K.; Kon, H.; Takada, S.; Ohno, T.; Watanabe, H. Immunohistochemical investigation of lymphatic vessel formation control in mouse tooth development. Lymphatic vessel-forming factors and receptors in tooth development in mice. Tissue Cell 2012, 44, 170–181.
  95. Dragica Dačić Simonović; Ljubinka Veličković Janković; Ana Ristić Petrović; Stefan Veličković; Aleksandra Petrović; Martina Rakonjac; Influence of Inflammation to Lymphangiogenesis in Human Dental Pulp. Acta Facultatis Medicae Naissensis 2013, 30, 15-19, 10.2478/v10283-012-0031-5.
  96. 4. Breslin, J.W.; Yang, Y.; Scallan, J.P.; Sweat, R.S.; Adderley, S.P.; Murfee, W.L. . Lymphatic Vessel Network Structure and Physiology; Comprehensive Physiology: NJ, USA, 2018; pp. 207–299.
  97. David G Jackson; The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1.. Trends in Cardiovascular Medicine 2003, 13, 1-7, 10.1016/s1050-1738(02)00189-5.
  98. David G. Jackson; Immunological functions of hyaluronan and its receptors in the lymphatics. Immunological Reviews 2009, 230, 216-231, 10.1111/j.1600-065x.2009.00803.x.
  99. Remko Prevo; Suneale Banerji; David Ferguson; Steven Clasper; David G. Jackson; Mouse LYVE-1 Is an Endocytic Receptor for Hyaluronan in Lymphatic Endothelium. Journal of Biological Chemistry 2001, 276, 19420-19430, 10.1074/jbc.m011004200.
  100. Jörg Wilting; Maria Papoutsi; Bodo Christ; Kypros H. Nicolaides; Constantin S. von Kaisenberg; Jörg Borges; G. Björn Stark; Kari Alitalo; Stanislav I. Tomarev; Charlotte Niemeyer; et al.Jochen Rössler The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. The FASEB Journal 2002, 16, 1271-1273, 10.1096/fj.01-1010fje.
  101. M. Rodriguez-Niedenführ; M. Papoutsi; B. Christ; Kypros Nicolaides; C.S. Von Kaisenberg; S. I. Tomarev; J. Wilting; Prox1 is a marker of ectodermal placodes, endodermal compartments, lymphatic endothelium and lymphangioblasts.. Brain Structure and Function 2001, 204, 399-406, 10.1007/s00429-001-0214-9.
  102. Yukihiro Saito; Transfection of Human Hepatocyte Growth Factor Gene Ameliorates Secondary Lymphedema via Promotion of Lymphangiogenesis. Circulation 2006, 114, 1177-1184, 10.1161/circulationaha.105.602953.
  103. Anna Martin; Hagen Gasse; Carsten Staszyk; Absence of lymphatic vessels in the dog dental pulp: an immunohistochemical study. Journal of Anatomy 2010, 217, 609-615, 10.1111/j.1469-7580.2010.01298.x.
  104. A. Kaipainen; J. Korhonen; Tuija Mustonen; V. W. van Hinsbergh; G. H. Fang; D. Dumont; M. Breitman; Kari Alitalo; Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.. Proceedings of the National Academy of Sciences 1995, 92, 3566-3570, 10.1073/pnas.92.8.3566.
  105. Georg Breier; Functions of the VEGF/VEGF Receptor System in the Vascular System. Seminars in Thrombosis and Hemostasis 2000, 26, 553-560, 10.1055/s-2000-13212.
  106. Tanja Veikkola; Lotta Jussila; Taija Makinen; Terhi Karpanen; Michael Jeltsch; Tatiana V. Petrova; Hajime Kubo; Gavin Thurston; Donald M. McDonald; Marc Achen; et al.Steven StackerKari Alitalo Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. The EMBO Journal 2001, 20, 1223-1231, 10.1093/emboj/20.6.1223.
  107. Marja Lohela; Maija Bry; Tuomas Tammela; Kari Alitalo; VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Current Opinion in Cell Biology 2009, 21, 154-165, 10.1016/j.ceb.2008.12.012.
  108. Anca Virtej; Sigbjørn Løes; Ole Iden; Athanasia Bletsa; Ellen Berggreen; Vascular endothelial growth factors signalling in normal human dental pulp: a study of gene and protein expression. European Journal of Oral Sciences 2013, 121, 92-100, 10.1111/eos.12019.
  109. Taina A. Partanen; Karri Paavonen; Lymphatic versus blood vascular endothelial growth factors and receptors in humans. Microscopy Research and Technique 2001, 55, 108-121, 10.1002/jemt.1162.
  110. Elizangela Partata Zuza; Ana Luiza Vanzato Carrareto; Raphael Carlos Comelli Lia; Juliana Rico Pires; Benedicto Egbert Corrêa de Toledo; Histopathological Features of Dental Pulp in Teeth with Different Levels of Chronic Periodontitis Severity. ISRN Dentistry 2012, 2012, 1-6, 10.5402/2012/271350.
  111. Bhat, N.V.B.K.S.; Kundabala, M.; Rao, A.K.; A rare case of uveitis as a complication of non vital tooth—A case report. Int. J. Clin. Dent. 2010, 3, 145–151.
  112. T. Mäkinen; C. Norrmen; T. V. Petrova; Molecular mechanisms of lymphatic vascular development. Cellular and Molecular Life Sciences 2007, 64, 1915-1929, 10.1007/s00018-007-7040-z.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)
ScholarVision Creations
Feedback